Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea: Double Blinded, Randomized, Placebo Drug Controlled, Parallel Designed, Multi-centered, Phase 2 Study.
Phase of Trial: Phase II
Latest Information Update: 01 May 2015
At a glance
- Drugs Mosapride; Probiotics
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 21 May 2013 Results presented at the Digestive Disease Week 2013.
- 13 Jan 2012 New trial record